Neogen Chemicals has scheduled a Board of Directors meeting on May 16, 2026, to evaluate the company’s financial performance. The leadership team will review the audited standalone and consolidated financial results for the quarter and the full financial year ending March 31, 2026. Additionally, the board will consider a recommendation for a final dividend for the fiscal year, subject to final approval at the upcoming 37th Annual General Meeting.
Financial Review and Annual Results
Neogen Chemicals is set to hold a key board meeting on Saturday, May 16, 2026. The primary agenda is to consider and approve the audited financial results, covering both standalone and consolidated performance for the quarter and the entire financial year that concluded on March 31, 2026.
Proposed Final Dividend
In addition to the financial review, the board will discuss the declaration of a final dividend on equity shares for the fiscal year 2025-26. Any recommended dividend will be presented for final approval by shareholders during the company’s 37th Annual General Meeting.
Trading Window Update
The company previously initiated a trading window closure on April 1, 2026. This restriction remains in effect and will conclude 48 hours following the official announcement of the audited financial results to the stock exchanges, ensuring compliance with internal governance protocols regarding sensitive financial data.
Source: BSE
